Synerkine Pharma B.v.

Sabine Versteeg

Cornelis Erik Hack

Niels Eijkelkamp

Jelena Popov-Čeleketić

Judith Prado Sanchez

Jelena Popov- Celeketic

The invention is concerned with a fusion protein comprising interleukin 13 and a regulatory cytokine, for example, an interleukin chosen from interleukin 4, interleukin 10, interleukin 27, interleukin 33, transforming growth factor beta 1, transforming growth factor beta 2, and interleukin 13, a nucleic acid molecule encoding such fusion protein, a vector comprising such nucleic acid molecule, and a host cell comprising such nucleic acid molecule or such vector. The invention further pertains to a method for producing such fusion protein. The fusion protein or a gene therapy vector encoding the fusion protein may be used in the prevention or treatment of a condition characterized by pathological pain, chronic pain, neuro-inflammation and/or or neurodegeneration.

Growing community of inventors

Tiel, Netherlands

Sabine Versteeg